Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Glucagon and Amino Acids Are Linked in a Mutual Feedback Cycle : The Liver-α-Cell Axis. / Holst, Jens J; Wewer Albrechtsen, Nicolai J; Pedersen, Jens; Knop, Filip K.

    In: Diabetes, Vol. 66, No. 2, 02.2017, p. 235-240.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    IDegLira Improves Both Fasting and Postprandial Glucose Control as Demonstrated Using Continuous Glucose Monitoring and a Standardized Meal Test. / Holst, Jens J; Buse, John B; Rodbard, Helena W; Linjawi, Sultan; Woo, Vincent C; Boesgaard, Trine Welløv; Kvist, Kajsa; Gough, Stephen C.

    In: Journal of Diabetes Science and Technology, Vol. 10, No. 2, 03.2016, p. 389-97.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Gut hormones and gastric bypass. / Holst, Jens J.

    In: Cardiovascular Endocrinology, Vol. 5, No. 3, 2016, p. 69-74.

    Research output: Contribution to journalReviewResearchpeer-review

  4. Published

    Oxyntomodulin : actions and role in diabetes. / Holst, Jens J.; Albrechtsen, Nicolai J. Wewer; Gabe, Maria Buur Nordskov; Rosenkilde, Mette Marie.

    In: Peptides, Vol. 100, 2018, p. 48-53.

    Research output: Contribution to journalReviewResearchpeer-review

  5. Published

    The pathogenesis of non-insulin dependent diabetes mellitus involves a defective expression of the GIP receptor. / Holst, Jens Juul; Gromada, Jesper Lindgren; Nauck, M.A.

    In: Diabetologia, No. 40, 1997, p. 984-986.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes. / Holst, Jens Juul; Knop, Filip K; Vilsbøll, Tina; Krarup, Thure; Madsbad, Sten.

    In: Diabetes Care, Vol. 34, No. Supplement 2, 05.2011, p. S251-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Combining GLP-1 receptor agonists with insulin : therapeutic rationales and clinical findings. / Holst, Jens Juul; Vilsbøll, T.

    In: Diabetes, Obesity and Metabolism, Vol. 15, No. 1, 01.2013, p. 3-14.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Incretin hormones and the satiation signal. / Holst, Jens Juul.

    In: International journal of obesity (2005), Vol. 37, No. 9, 09.2013, p. 1161-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Release of galanin from isolated, perfused porcine adrenal glands. Role of the splanchnic nerves. / Holst, Jens Juul; Ehrhart-Bornstein, Monika; Messell, T.

    In: Amer.J. Physiology, No. 261, 1991, p. E31-E40.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Nitric oxide (NO) is an important element in neurally induced pancreatic exocrine secretion in pigs. / Holst, Jens Juul; Rasmussen, Torben Norre; Schmidt, P.

    In: Am J Physiology, No. 29, 1994, p. G206-G213.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Glucagon and glucagon-like peptides 1 and 2. / Holst, Jens Juul.

    In: Results and Problems in Cell Differentiation, Vol. 50, 01.01.2010, p. 121-35.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. Published

    Gastric inhibitory polypeptide analogues : do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1? / Holst, Jens Juul.

    In: BioDrugs, Vol. 16, No. 3, 2002, p. 175-81.

    Research output: Contribution to journalJournal articleResearchpeer-review

  13. Published

    Mechanisms in bariatric surgery : Gut hormones, diabetes resolution, and weight loss. / Holst, Jens Juul; Madsbad, Sten; Bojsen-Møller, Kirstine N; Svane, Maria Saur; Jørgensen, Nils Bruun; Dirksen, Carsten; Martinussen, Christoffer.

    In: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, Vol. 14, No. 5, 05.2018, p. 708-714.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    Glucagon-like peptide 1: physiology and therapeutic potential. / Holst, Jens Juul.

    In: Endocrinology and Diabetes, No. 12, 2005, p. 56-62.

    Research output: Contribution to journalJournal articleResearch

  15. Published

    Long-acting glucagon-like peptide-1 receptor agonist-status December 2018. / Holst, Jens Juul.

    In: Annals of Translational Medicine, Vol. 7, No. 5, 2019.

    Research output: Contribution to journalEditorialResearch

  16. Published

    On the physiology of GIP and GLP-1. / Holst, Jens Juul.

    In: Hormone and Metabolic Research. Supplement, Vol. 36, No. 11-12, 19.01.2005, p. 747-54.

    Research output: Contribution to journalJournal articleResearchpeer-review

  17. Published

    On the physiology of GIP and GLP-1. / Holst, Jens Juul.

    In: Horm Metab Res, No. 36, 2004, p. 747-754.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Treatment of Type 2 diabetes mellitus based on glucagon-like peptide-1. / Holst, Jens Juul.

    In: Expert Opinion on Investigational Drugs, Vol. 8, No. 9, 09.1999, p. 1409-15.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Enteroendocrine secretion of gut hormones in diabetes, obesity and after bariatric surgery. / Holst, Jens Juul.

    In: Current Opinion in Pharmacology, Vol. 13, No. 6, 12.2013, p. 983-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Postprandial insulin secretion after gastric bypass surgery : the role of glucagon-like peptide 1. / Holst, Jens Juul.

    In: Diabetes, Vol. 60, No. 9, 09.2011, p. 2203-2205.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Pancreatic safety of GLP-1-based therapeutic agents : further insights from rodent studies? / Holst, Jens Juul.

    In: Diabetologia, Vol. 56, No. 9, 09.2013, p. 1869-72.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Fedtvaevet og insulin-resistens: resistin og adiponectin. / Holst, Jens Juul; Binderup, Martin.

    In: Ugeskrift for læger, Vol. 164, No. 16, 2002, p. 2173-6.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Insulin and Glucagon : Partners for Life. / Holst, Jens Juul; Holland, William; Gromada, Jesper; Lee, Young; Unger, Roger H; Yan, Hai; Sloop, Kyle W; Kieffer, Timothy J; Damond, Nicolas; Herrera, Pedro L.

    In: Endocrinology, Vol. 158, No. 4, 01.04.2017, p. 696-701.

    Research output: Contribution to journalReviewResearchpeer-review

  24. Published

    Glucagon-like peptide-1, glucose homeostasis and diabetes. / Holst, Jens Juul; Deacon, Carolyn F; Vilsbøll, Tina; Krarup, Thure; Madsbad, Sten.

    In: Trends in Molecular Medicine, Vol. 14, No. 4, 2008, p. 161-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  25. Published

    The physiology of glucagon-like peptide 1. / Holst, Jens Juul.

    In: Physiological Reviews, Vol. 87, No. 4, 2007, p. 1409-39.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Vagal control of the release of somatostatin, vasoactive intestinal polypeptide, gastrin releasing peptide and HC1 from porcine non-antral stomach. / Holst, Jens Juul; Skak-Nielsen, T.; Ørskov, Cathrine; Poulsen, S.S.

    In: Scandinavian Journal of Gastroenterology, No. 27, 1992, p. 677-685.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    10.Differences in the control of somatostatin release from antrum and fundus. / Holst, Jens Juul.

    The Stomach as an Endocrine Organ. Amsterdam : Aspen Publishers, 1991. p. 139-149.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  28. Published

    Holder GLP-1 som nyt terapeutisk princip i diabetesbehandlingen hvad det lovede? / Holst, Jens Juul.

    In: Tidsskrift for Diabetesbehandling, No. 2(7), 1997, p. 16-22.

    Research output: Contribution to journalJournal articleResearch

  29. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of Dpp-IV inhibitors. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  30. Published

    Regulation of glucagon secretion by incretins. / Holst, Jens Juul; Christensen, M; Lund, A; de Heer, J; Svendsen, B; Kielgast, U; Knop, F K.

    In: Diabetes, Obesity and Metabolism, Vol. 13 , No. Suppl 1, 10.2011, p. 89-94.

    Research output: Contribution to journalJournal articleResearchpeer-review

  31. Published

    The incretin system and its role in type 2 diabetes mellitus. / Holst, Jens Juul; Vilsbøll, Tina; Deacon, Carolyn F.

    In: Molecular and Cellular Endocrinology, Vol. 297, No. 1-2, 2008, p. 127-136.

    Research output: Contribution to journalJournal articleResearchpeer-review

  32. Published

    Bone resorption is decreased postprandially by intestinal factors and glucagon-like peptide-2 is a possible candidate. / Holst, Jens Juul; Hartmann, Bolette; Gottschalck, Ida B; Jeppesen, Palle B; Miholic, Johannes; Henriksen, Dennis Bang.

    In: Scandinavian Journal of Gastroenterology, Vol. 42, No. 7, 07.2007, p. 814-20.

    Research output: Contribution to journalJournal articleResearchpeer-review

  33. Published

    Enteroglucagon. / Holst, Jens Juul.

    In: Annual Reviews of Physiology, No. 59, 1997, p. 257-272.

    Research output: Contribution to journalJournal articleResearchpeer-review

  34. Published

    Glucagon-like peptide-1 - et nyt hormon med mulig anvendelse i diabetesbehandlingen. / Holst, Jens Juul.

    In: Tidsskrift for Diabetesbehandling, No. 3, 1993, p. 33-39.

    Research output: Contribution to journalJournal articleResearch

  35. Published

    The incretin approach for diabetes treatment: modulation of islet hormone release by GLP-1 agonism. / Holst, Jens Juul; Ørskov, Cathrine.

    In: Diabetes, Vol. 53 Suppl 3, 2004, p. S197-204.

    Research output: Contribution to journalJournal articleResearchpeer-review

  36. Published

    7 Heterogeneity of Islet Hormones. / Holst, Jens Juul; Ørskov, Cathrine; Bersani, Maurizio.

    The Endocrine Pancreas. New York : Raven Press, 1991. p. 125-152.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  37. Published

    Which to choose, an oral or an injectable glucagon-like peptide-1 receptor agonist? / Holst, Jens Juul.

    In: Lancet, Vol. 394, No. 10192, 2019, p. 4-6.

    Research output: Contribution to journalEditorialResearchpeer-review

  38. Published

    The physiology and pharmacology of incretins in type 2 diabetes mellitus. / Holst, Jens Juul.

    In: Diabetes, Obesity and Metabolism, Vol. 10, No. Suppl. 3, 2008, p. 14-21.

    Research output: Contribution to journalJournal articleResearchpeer-review

  39. Published

    Human Glucagon-like peptide-1, - six important topics. / Holst, Jens Juul.

    Gastrointestinal Tract and Endocrine System.. Dordrecht/Boston/London : Kluwer Academic Publishers, 1995. p. 537-546.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  40. Published

    Glucagon-like peptide-1 : from extract to agent. The Claude Bernard Lecture, 2005. / Holst, Jens Juul.

    In: Diabetologia, Vol. 49, No. 2, 02.2006, p. 253-60.

    Research output: Contribution to journalJournal articleCommunication

  41. Published

    Overview of incretin hormones. / Holst, Jens Juul; Lasalle, JR.

    In: Journal of Family Practice, Vol. 57, No. 9, 2008, p. 53-59.

    Research output: Contribution to journalJournal articleResearchpeer-review

  42. Published

    Incretin hormones as a target for therapy. / Holst, Jens Juul.

    Handbook of Incretin-based Therapies in Type 2 Diabetes. ed. / Stephen Gough. Springer, 2016. p. 11-30.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  43. Published

    Kardiale virkninger af glukagonlignende peptid 1. / Holst, Jens Juul.

    In: Ugeskrift for Laeger, Vol. 172, No. 41, 11.10.2010, p. 2821.

    Research output: Contribution to journalJournal articleResearchpeer-review

  44. Published

    Role of classical and peptidergic neurotransmitters in insulin secretion. / Holst, Jens Juul.

    Nutrient Regulation of Insulin Secretion. Portland Press, 1991.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  45. Published

    Implementation of GLP-1 based therapy of type 2 diabetes mellitus using DPP-IV inhibitors. / Holst, Jens Juul.

    In: Advances in Experimental Medicine and Biology, Vol. 524, 2003, p. 263-79.

    Research output: Contribution to journalJournal articleResearchpeer-review

  46. Published

    Transmitters in the control of gastrin and acid secretion in the pig stomach. / Holst, Jens Juul; Nørre Ramussen, T.; Schmidt, P.; Poulsen, S.S.

    Gastrin. New York : Raven Press, 1993. p. 243-258.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  47. Published

    For debate: Are antidiabetic actions of DPP-IV inhibitors mediated by glucagon-like peptide- 1? / Holst, Jens Juul; Deacon, Carolyn F.

    In: Diabetologia, No. 48, 2005, p. 612-615.

    Research output: Contribution to journalJournal articleResearchpeer-review

  48. Published

    Enhancing insulin secretion: novel approaches to glucose control. / Holst, Jens Juul.

    In: Diabetes Voice, No. 49, 2004, p. 20-22.

    Research output: Contribution to journalJournal articleResearchpeer-review

  49. Published

    Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. / Holst, Jens Juul.

    In: Diabetes - Metabolism: Research and Reviews (Print Edition), Vol. 18, No. 6, 2002, p. 430-41.

    Research output: Contribution to journalJournal articleResearchpeer-review

  50. Published

    Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors. / Holst, Jens Juul.

    In: Expert Opinion on Emerging Drugs, Vol. 9, No. 1, 2004, p. 155-66.

    Research output: Contribution to journalJournal articleResearchpeer-review

  51. Published

    The Gut : A Key to the Pathogenesis of Type 2 Diabetes? / Holst, Jens Juul; Pedersen, Jens; Wewer Albrechtsen, Nicolai Jacob; Knop, Filip Krag.

    In: Metabolic Syndrome and Related Disorders, Vol. 15, No. 6, 08.2017, p. 259-262.

    Research output: Contribution to journalReviewResearchpeer-review

  52. Published

    Neuroprotective properties of GLP-1 : theoretical and practical applications. / Holst, Jens Juul; Burcelin, Remy; Nathanson, Esther.

    In: Current Medical Research and Opinion, Vol. 27, No. 3, 2011, p. 547-58.

    Research output: Contribution to journalJournal articleResearchpeer-review

  53. Published

    Will GLP-1 treatment increase blood pressure? Summary and comment. / Holst, Jens Juul.

    In: Diabetes Monitor, No. 15, 2003, p. 15-17.

    Research output: Contribution to journalJournal articleResearchpeer-review

  54. Published

    Mechanisms of surgical control of type 2 diabetes : GLP-1 is key factor. / Holst, Jens Juul; Madsbad, Sten.

    In: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery, Vol. 12, No. 6, 07.2016, p. 1236-42.

    Research output: Contribution to journalJournal articleResearchpeer-review

  55. Published

    Assays for Peptide Products of Somatostatin Gene Expression. / Holst, Jens Juul; Bersani, Maurizio.

    In: Methods in Neurosciences, No. 5, 1991, p. 3-22.

    Research output: Contribution to journalJournal articleResearchpeer-review

  56. Published

    Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors. / Holst, Jens Juul; Deacon, C F.

    In: Diabetologia, Vol. 48, No. 4, 04.2005, p. 612-5.

    Research output: Contribution to journalJournal articleResearchpeer-review

  57. Published

    Searching for the physiological role of glucose-dependent insulinotropic polypeptide. / Holst, Jens Juul; Windeløv, Johanne Agerlin; Boer, Geke Aline; Pedersen, Jens; Svendsen, Berit; Christensen, Mikkel; Torekov, Signe; Asmar, Meena; Hartmann, Bolette; Nissen, Anne.

    In: Journal of Diabetes Investigation, Vol. 7, No. S1, 01.04.2016, p. 8-12.

    Research output: Contribution to journalJournal articleResearchpeer-review

  58. Published

    Glucagon-like peptide-1 (GLP-1) - A newly discovered Gl Hormone. Review. / Holst, Jens Juul.

    In: Today in Medicine. Gastroenterology, No. 107, 1994, p. 1848-1855.

    Research output: Contribution to journalJournal articleResearchpeer-review

  59. Published

    Posttranslational processing of proglucagon and postsecretory fate of proglucagon products. / Holst, Jens Juul; Ørskov, C.; Hartmann, Bolette; Deacon, C.F.

    The Insulinotropic Gut Hormone Glucagon-like Peptide-1.. Basel : Karger, 1997. p. 24-48.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  60. Published

    Chap.10. Degradation of glucagons. / Holst, Jens Juul.

    Degradation of Bioactive Substances: Physiology and Pathophysiology. Boca Raton, Florida : CRC Press, 1991. p. 167-180.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  61. Published

    Roles of the Gut in Glucose Homeostasis. / Holst, Jens Juul; Gribble, Fiona; Horowitz, Michael; Rayner, Chris K.

    In: Diabetes Care, Vol. 39, No. 6, 06.2016, p. 884-92.

    Research output: Contribution to journalJournal articleResearchpeer-review

  62. Published

    GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes. / Holst, Jens Juul; Seino, Yutaka.

    In: Diabetes Research and Clinical Practice, Vol. 85, No. 1, 2009, p. 1-3.

    Research output: Contribution to journalJournal articleResearchpeer-review

  63. Published

    Semaglutide seems to be more effective the other GLP-1Ras. / Holst, Jens Juul; Madsbad, Sten.

    In: Annals of Translational Medicine, Vol. 5, No. 24, 505, 12.2017.

    Research output: Contribution to journalComment/debateResearch

  64. Published

    Glucagon-like peptide 1 - a new hormone which may change the treatment of non-insulin dependent diabetes mellitus. / Holst, Jens Juul; Ørskov, Cathrine.

    In: MedView, No. 6, 1992, p. 259-263.

    Research output: Contribution to journalJournal articleResearchpeer-review

  65. Published

    Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans. / Holst, Jens Juul; Gromada, Jesper.

    In: American Journal of Physiology: Endocrinology and Metabolism, Vol. 287, No. 2, 2004, p. E199-206.

    Research output: Contribution to journalJournal articleResearchpeer-review

  66. Published

    Effect of intestinal inhibitory peptides on vagally induced secretion from isolated perfused porcine pancreas. / Holst, Jens Juul; Rasmussen, T.N.; Harling, H.; Schmidt, P.

    In: Pancreas, No. Vol. 8, no. 1, 1993, p. 80-87.

    Research output: Contribution to journalJournal articleResearchpeer-review

  67. Published

    Isolated organs as replacements for vertebrate animals. / Holst, Jens Juul.

    Handbook of Laboratory Animal Science. USA : CRC Press, 1994. p. 397-408.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  68. Published

    Is there a place for incretin therapies in obesity and prediabetes? / Holst, Jens Juul; Deacon, Carolyn F.

    In: Trends in Endocrinology and Metabolism, Vol. 24, No. 3, 13.02.2013, p. 145-152.

    Research output: Contribution to journalJournal articleResearchpeer-review

  69. Published

    Neural regulation of pancreatic exocrine funktion. / Holst, Jens Juul.

    In: The Pancreas: Biology, Pathobiology an Disease, 1993, p. 381-402.

    Research output: Contribution to journalJournal articleResearchpeer-review

  70. Published

    Glucagon and other proglucagon-derived peptides. / Holst, Jens Juul; Ørskov, Cathrine.

    Gut Peptides: Biochemistry and Physiology. New York : Raven Press, 1994. p. 305-340.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  71. Published

    Potential new approaches to modifying intestinal GLP-1 secretion in patients with type 2 diabetes mellitus : focus on bile acid sequestrants. / Holst, Jens Juul; McGill, Maria A.

    In: Clinical Drug Investigation, Vol. 32, No. 1, 2012, p. 1-14.

    Research output: Contribution to journalJournal articleResearchpeer-review

  72. Published

    Glucagon-like peptides 1 and 2, enteroglucagon, glicentin and oxyntomodulin. / Holst, Jens Juul; Deacon, Carolyn F.; Hartmann, Bolette; Pedersen, Jens.

    Handbook of Biologically Active Peptides . ed. / AJ Kastin. 2. ed. Elsevier, 2013. p. 1241-1250.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterEducation

  73. Published

    Erratum to semaglutide seems to be more effective the other GLP-1Ras. / Holst, Jens Juul; Madsbad, Sten.

    In: Annals of Translational Medicine, Vol. 6, No. 3, 2018, p. 74.

    Research output: Contribution to journalJournal articleResearchpeer-review

  74. Published

    Non-insulin-dependent diabetes mellitus - new drugs? / Holst, Jens Juul.

    In: Drug Discovery Today, No. 2, 1997, p. 128-129.

    Research output: Contribution to journalJournal articleResearchpeer-review

  75. Published

    Somatostatin is an essential paracrine link in acid inhibition of gastrin secretion. / Holst, Jens Juul; Ørskov, Cathrine; Poulsen, S.S.

    In: Digestion, No. 51, 1992, p. 95-102.

    Research output: Contribution to journalJournal articleResearchpeer-review

  76. Published

    Incretin based therapies : do they hold their promise? / Holst, Jens Juul.

    In: Journal of Diabetes, Vol. 4, No. 1, 2012, p. 4-7.

    Research output: Contribution to journalJournal articleResearchpeer-review

  77. Published

    Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. / Holst, Jens Juul; Deacon, Carolyn F.

    In: Current Opinion in Pharmacology, Vol. 4, No. 6, 2004, p. 589-96.

    Research output: Contribution to journalJournal articleResearchpeer-review

  78. Published

    Neuromediators in the control of pancreatic secretion. / Holst, Jens Juul.

    Neuromediators in the control of pancreatic secretion. Torun : Polish Physiological Society, 1993. p. 72-78.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  79. Published

    Gut hormones and intestinal function. / Holst, Jens Juul; Schmidt, P.

    The Gut as an Endocrine Organ. Clinics in Endocrinology and Metabolism, Vol 8. Bailliere, 1994. p. 137-164.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  80. Published

    Secretion of neurotensin from isolated perfused porcine ileum. / Holst Pedersen, J; Knuthsen, S; Bernabei, M; Orskov, C; Holst, J J.

    In: Regulatory Peptides, Vol. 21, No. 1-2, 05.1988, p. 13-9.

    Research output: Contribution to journalJournal articleResearchpeer-review

  81. Published

    Increased Postprandial Response of Glucagon-Like Peptide-2 in Patients with Chronic Pancreatitis and Pancreatic Exocrine Insufficiency. / Hornum, Mads; Pedersen, Jan F; Larsen, Steen; Olsen, Ole; Holst, Jens J; Knop, Filip K.

    In: Pancreatology, Vol. 10, No. 2-3, 2010, p. 201-207.

    Research output: Contribution to journalJournal articleResearchpeer-review

  82. Published

    Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. / Hvidberg, A; Nielsen, M T; Hilsted, J; Orskov, C; Holst, J J.

    In: Metabolism, Vol. 43, No. 1, 01.1994, p. 104-8.

    Research output: Contribution to journalJournal articleResearchpeer-review

  83. Published

    Effect of glucagon-like peptide-1 (proglucagon 78-107 amide) on hepatic glucose production in healthy man. / Hvidberg, A.; Nielsen, M.T.; Hilsted, J.; Holst, Jens Juul; Ørskov, Cathrine.

    In: Metabolism, No. 43, 1994, p. 104-108.

    Research output: Contribution to journalJournal articleResearchpeer-review

  84. Published

    Effect of glucagon-like peptide-1 (proglucagon 78 - 107 amide) on hepatic glucose production in healthy man. / Hvidberg, A.; Nielsen, M.T.; Hilsted, J.; Ørskov, Cathrine; Holst, Jens Juul.

    In: Metabolism, No. 43, 1994, p. 104-108.

    Research output: Contribution to journalJournal articleResearchpeer-review

  85. Published

    Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome : An open-label pilot study. / Hvistendahl, Mark; Brandt, Christopher Filtenborg; Tribler, Siri; Naimi, Rahim Mohammad; Hartmann, Bolette; Holst, Jens Juul; Rehfeld, Jens Frederik; Hornum, Mads; Andersen, Jens Rikardt; Henriksen, Birthe Merete; Brøbech Mortensen, Per; Jeppesen, Palle Bekker.

    In: Journal of Parenteral and Enteral Nutrition, Vol. 42, No. 1, 2018, p. 112-121.

    Research output: Contribution to journalJournal articleResearchpeer-review

  86. Published

    The glucagon-like peptide-1 receptor agonist liraglutide reduces jejunostomy output and improves intestinal absorption in short bowel syndrome patients with intestinal failure : A pilot study. / Hvistendahl, Mark; Brandt, Christopher F.; Tribler, Siri; Naimi, Rahim; Hartmann, Bolette; Holst, Jens Juul; Rehfeld, Jens Frederik; Hornum, Mads; Andersen, Jens Rikardt; Mortensen, Per B.; Jeppesen, Palle B.

    2015. Abstract from Årsmøde i Dansk Selskab for Klinisk Ernæring, Aarhus, Denmark.

    Research output: Contribution to conferenceConference abstract for conferenceResearchpeer-review

  87. Published

    The diurnal variation of bone formation is attenuated in adult patients with type 2 diabetes. / Hygum, Katrine; Starup-Linde, Jakob; Harslor, Torben; Jorgensen, Niklas Rye; Hartmann, Bolette; Holst, Jens Juul; Langdahl, Bente L.

    In: European Journal of Endocrinology, Vol. 181, No. 3, 2019, p. 221-231.

    Research output: Contribution to journalJournal articleResearchpeer-review

  88. Published

    Glucose ingestion causes cardiac repolarization disturbances in type 1 long QT syndrome patients and healthy subjects. / Hyltén-Cavallius, Louise; Iepsen, Eva W; Christiansen, Michael; Graff, Claus; Linneberg, Allan; Pedersen, Oluf; Holst, Jens J; Hansen, Torben; Torekov, Signe S; Kanters, Jørgen K.

    In: Heart Rhythm, Vol. 14, No. 8, 08.2017, p. 1165-1170.

    Research output: Contribution to journalJournal articleResearchpeer-review

  89. Published

    Patients with Long QT Syndrome Due to Impaired hERG-encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated with Reactive Hypoglycemia. / Hyltén-Cavallius, Louise; Iepsen, Eva W; Wewer Albrechtsen, Nicolai J; Svendstrup, Mathilde; Lubberding, Anniek F; Hartmann, Bolette; Jespersen, Thomas; Linneberg, Allan; Christiansen, Michael; Vestergaard, Henrik; Pedersen, Oluf; Holst, Jens J; Kanters, Jørgen K; Hansen, Torben; Torekov, Signe S.

    In: Circulation, Vol. 135, No. 18, 2017, p. 1705-1719.

    Research output: Contribution to journalJournal articleResearchpeer-review

  90. Published

    Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice. / Hytting-Andreasen, Rasmus; Balk-Møller, Emilie; Hartmann, Bolette; Pedersen, Jens; Windeløv, Johanne Agerlin; Holst, Jens Juul; Kissow, Hannelouise.

    In: PLoS ONE, Vol. 13, No. 6, e0198046, 2018, p. 1-14.

    Research output: Contribution to journalJournal articleResearchpeer-review

  91. Published

    Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity. / Høi-Hansen, Thomas; Pedersen-Bjergaard, Ulrik; Andersen, Rikke Due; Kristensen, Peter Lommer; Thomsen, Carsten; Kjaer, Troels; Høgenhaven, Hans; Smed, Annelise; Holst, Jens Juul; Dela, Flemming; Boomsma, Frans; Thorsteinsson, Birger; Høi-Hansen, Thomas; Pedersen-Bjergaard, Ulrik; Andersen, Rikke Due; Kristensen, Peter Lommer; Thomsen, Carsten; Kjaer, Troels; Høgenhaven, Hans; Smed, Annelise; Holst, Jens Juul; Dela, Flemming; Boomsma, Frans; Thorsteinsson, Birger.

    In: Journal of the Renin-Angiotensin-Aldosterone System, Vol. 10, No. 4, 2009, p. 216-29.

    Research output: Contribution to journalJournal articleResearchpeer-review

  92. Published

    Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity. / Høi-Hansen, Thomas; Pedersen-Bjergaard, Ulrik; Andersen, Rikke Due; Kristensen, Peter Lommer; Thomsen, Carsten; Kjaer, Troels; Høgenhaven, Hans; Smed, Annelise; Holst, Jens Juul; Dela, Flemming; Boomsma, Frans; Thorsteinsson, Birger.

    In: Journal of the Renin-Angiotensin-Aldosterone System, Vol. 10, No. 4, 12.2009, p. 216-29.

    Research output: Contribution to journalJournal articleResearchpeer-review

  93. Published

    Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes. / Højberg, P V; Zander, M; Vilsbøll, T; Knop, F K; Krarup, T; Vølund, A; Holst, Jens Juul; Madsbad, S.

    In: Diabetologia, Vol. 51, No. 4, 04.2008, p. 632-40.

    Research output: Contribution to journalJournal articleResearchpeer-review

  94. Published

    Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes. / Højberg, P V; Vilsbøll, T; Zander, M; Knop, F K; Krarup, T; Vølund, A; Holst, Jens Juul; Madsbad, S.

    In: Diabetic Medicine Online, Vol. 25, No. 11, 11.2008, p. 1268-75.

    Research output: Contribution to journalJournal articleResearchpeer-review

  95. Published

    Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. / Højberg, P V; Vilsbøll, T; Rabøl, R; Knop, F K; Bache, M; Krarup, T; Holst, Jens Juul; Madsbad, S.

    In: Diabetologia, Vol. 52, No. 2, 2008, p. 199-207.

    Research output: Contribution to journalJournal articleResearchpeer-review

  96. Published

    Reference intervals for plasma glucose, insulin, proinsulin, C-peptide and counterregulatory factors during a 72-hour fast in healthy human subjects. / Højlund, K.; Eshøj, O.; Christensen, M.W.; Skjærbæk, C.; Frystyk, J.; Holst, J.J.; Koldkjær, O.; Møller J., D.; Beck-Nielsen, Henning.

    In: American Journal of Physiology., No. 280, 2001, p. E50-E58.

    Research output: Contribution to journalJournal articleResearchpeer-review

  97. Published

    alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in Type 2 diabetic patients. / Hücking, K; Kostic, Z; Pox, C; Ritzel, R; Holst, Jens Juul; Schmiegel, W; Nauck, M A.

    In: Diabetic Medicine, Vol. 22, No. 4, 04.2005, p. 470-6.

    Research output: Contribution to journalJournal articleResearchpeer-review

  98. Published

    Alpha-Glucosidase inhibition (Acarbose) fails to enhance secretion of glucagons-like peptide 1(7-36 amide) and to delay gastric emptying in type 2 diabetic patients. / Hücking, K.; Kostic, Z.; Pox, C.; Ritzel, R.; Holst, Jens Juul; Schmiegel, W.; Nauck, M.A.

    In: Diabet. Med., No. 22, 2005, p. 470-476.

    Research output: Contribution to journalJournal articleResearch

  99. Published

    Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: an investigator-initiated, randomised, placebo-controlled trial. / Idorn, T.; Knop, F. K.; Jorgensen, M. B.; Jensen, T.; Resuli, M.; Hansen, P. M.; Christensen, Karl Bang; Holst, J. J.; Hornum, M.; Feldt-Rasmussen, B.

    In: Diabetologia, Vol. 57, No. 1 supplement, 909, 09.2014, p. S370-S371.

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  100. Published

    Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease : protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study. / Idorn, Thomas; Knop, Filip K; Jørgensen, Morten; Jensen, Tonny; Resuli, Marsela; Hansen, Pernille M; Christensen, Karl B; Holst, Jens Juul; Hornum, Mads; Feldt-Rasmussen, Bo.

    In: B M J Open, Vol. 3, No. 4, e002764, 26.04.2013, p. 1-10.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 12 3 4 5 6 7 8 9 ...15 Next

ID: 4207